PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
21-Feb-2024 LATITUDE phase III interim trial data indicates ViiV Healthcare’s long-acting injectable HIV treatment Cabenuva (cabotegravir + rilpivirine) has superior efficacy compared to daily therapy in individuals living with HIV who have adherence challenges GSK 
21-Feb-2024 Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD Evaxion Biotech A/S
21-Feb-2024 Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its Lead Oncology Program Mestag Therapeutics
20-Feb-2024 RSSL announces new Innovation Hub to support biotech companies with dedicated laboratory space and flexible support services RSSL
20-Feb-2024 Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6 Omnix Medical
19-Feb-2024 Certa Therapeutics’ FT011 Granted US FDA Fast Track for the Treatment of Systemic Sclerosis Certa Therapeutics (Certa),
19-Feb-2024 CROs Continue to Choose Oracle to Support their Operations Oracle Life Sciences CRO
19-Feb-2024 Oncopeptides ensures five years extended market exclusivity for Pepaxti in Europe Oncopeptides AB
19-Feb-2024 ABPI launches new prescribing support guide for healthcare professionals ABPI
19-Feb-2024 Alfa Chemistry Launches MOF Chemicals for the Science Community Alfa Chemistry
19-Feb-2024 Alfa Chemistry Launches Dozens of Best-Selling Graphene Products Alfa Chemistry
19-Feb-2024 Alfa Chemistry  Unveils Expanded Assortment of Derivatization Reagents for Use in Gas Chromatography (GC) Alfa Chemistry
18-Feb-2024 Amerigo Scientific Launches DOPC Nanodiscs as An Invaluable Tool for Handling Membrane Proteins Amerigo Scientific
15-Feb-2024 DelSiTech and Tolmar Announce Global License and Development Agreement DelSiTech
15-Feb-2024 Further funding for new device to improve treatment of anal fistula The University of Birmingham
15-Feb-2024 REAL-WORLD EVIDENCE DEMONSTRATES FEASIBILITY AND SAFETY OF OUTPATIENT ADMINISTRATION OF YESCARTA® (AXICABTAGENE CILOLEUCEL) Kite, a Gilead Company
14-Feb-2024 ESMT Berlin and BCG publish index comparing biotech innovation hubs in Europe DEEP Institute at ESMT Berlin
13-Feb-2024 New six-figure fund to support talented individuals work across industry, academia and the NHS The Academy of Medical Sciences
13-Feb-2024 Anocca Appoints Martin Welschof to Board of Directors Anocca AB
13-Feb-2024 DelSiTech and Tolmar Announce Global License and Development Agreement DelSiTech